// App-Quantinova.ai

362 : The Renal Activity Index for Lupus (RAIL) Identifies Active Renal Disease in SLE Patients and Its Longitudinal Score Associates with Renal Responses in Lupus Nephritis

Researchers

Presenter

  • Hermine I. Brunner

Principal Investigators

  • Catharina Lindholm

  • Ellen Cody

  • Prasad Devarajan

  • Bin Huang

  • Dominic Sinibaldi

  • Madhu Ramaswamy

  • Jacob Knagenhjelm

  • Tingting Qiu

  • Frederick Jones

  • Philip Brohawn

  • Raj Tummala

  • Wendy White

Medical Centers

  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca, Gaithersburg, MD

  • AstraZeneca, Gothenburg, Sweden

  • Astra Zeneca, Cambridge, United Kingdom

Locations

  • United States

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Lupus nephritis

  • Renal disease

  • Nephritis

  • Lupus

Biomarkers

  • ATPase H+ Transporting Accessory Protein 2

  • Progesterone receptor

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02547922

  • NCT02446912

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved